CDNA logo

CareDx, Inc (CDNA)

Profile

Full Name

CareDx, Inc

Ticker

NASDAQ: CDNA

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

July 17, 2014

Indexes

Not included

Website

http://caredx.com

Employees

644

Key Details

Price

$12.79(-0.39%)

Market cap

$712.15M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$333.79M(+19.07% YoY)

Annual EPS

$0.93(+126.27% YoY)

PE ratio

11.12

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $12.79
    CDNA price is $12.79

    30-Day Relative Volume

    0.48
    CDNA 30-day relative volume is 0.48

    Price Performance

    Price Most recent change

    -0.39%
    CDNA price was down -0.39% on Jul 25, 2025

    Price YTD change

    -40.26%
    CDNA price is down -40.26% since January 1st

    Price 1-year change

    -32.22%
    CDNA price is down -32.22% year-on-year

    Price 3-year change

    -45.94%
    CDNA price is down -45.94% over the past 3 years

    Price Range

    Price All-time high

    $99.83
    CDNA price is currently -87.19% below its historical high of $99.83

    Price 3-year low

    $4.80
    CDNA price is currently +166.46% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $712.15M
    CDNA market capitalization is $712.15 million

    Market cap 3-year change

    -43.55%
    CDNA market capitalization is down -43.55% over the past 3 years

    Market cap All-time high

    $4.95B
    CDNA market capitalization is currently -85.62% below its historical high of $4.95 billion

    Market cap sector rank

    69.91%
    CDNA market capitalization is higher than 69.91% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +5.82%
    CDNA shares outstanding is up +5.82% year-on-year

    Shares Outstanding 3-Year Change

    +4.42%
    CDNA shares outstanding is up +4.42% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.29
    CDNA beta is 1.29

    200-day SMA

    $20.65
    CDNA price is currently -38.06% below its 200-day simple moving average

    50-day SMA

    $17.77
    CDNA price is currently -28.03% below its 50-day simple moving average

    RSI

    29.88
    CDNA 14-day relative strength index is 29.88

    Volume

    0.48
    CDNA 30-day relative volume is 0.48

    ATR

    $1.06
    CDNA average true range is $1.06

    10-day Historical Volatility

    201.27%
    CDNA 10-day historical volatility is 201.27%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $333.79M
    CDNA annual revenue is $333.79 million

    Revenue Analysts estimate

    $368.97M
    CDNA annual revenue is currently -9.54% lower than the consensus analysts' forecast

    Revenue 1-year change

    +19.07%
    CDNA annual revenue is up +19.07% year-on-year

    Revenue Sector rank

    69.6%
    CDNA annual revenue is higher than 69.6% of companies in Healthcare sector

    EPS

    EPS

    $0.93
    CDNA annual earnings per share is $0.93

    EPS Analysts estimate

    $0.57
    CDNA annual earnings per share is currently +63.73% higher than the consensus analysts' forecast

    EPS 1-year change

    +126.27%
    CDNA annual earnings per share is up +126.27% year-on-year

    EPS Sector rank

    88.8%
    CDNA annual earnings per share is higher than 88.8% of companies in Healthcare sector

    Profit

    Gross profit

    $224.16M
    CDNA annual gross profit is $224.16 million

    Gross margin

    67.16%
    CDNA annual gross profit margin is 67.16%

    Operating profit

    -$53.75M
    CDNA annual operating income is -$53.75 million

    Operating margin

    -16.10%
    CDNA annual operating profit margin is -16.10%

    Net income

    $52.55M
    CDNA annual net profit is $52.55 million

    Net margin

    15.74%
    CDNA annual net profit margin is 15.74%

    Expenses

    Total expenses

    $387.54M
    CDNA annual total expenses is $387.54 million

    Operating expenses

    $277.91M
    CDNA annual total operating expenses is $277.91 million

    Cost of goods sold

    $109.63M
    CDNA annual cost of goods sold is $109.63 million

    Selling, general & administrative expenses

    $205.50M
    CDNA annual SGA is $205.50 million

    Depreciation and amortization

    $19.76M
    CDNA annual depreciation & amortization is $19.76 million

    Interest expense

    -
    CDNA annual interest expense value is unknown

    Income tax

    $310.00K
    CDNA annual income tax is $310.00 thousand

    EBIT & EBITDA

    EBIT

    -$53.75M
    CDNA annual earnings before interest & taxes is -$53.75 million

    EBITDA

    -$33.99M
    CDNA annual EBITDA is -$33.99 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $491.05M
    CDNA annual total assets is $491.05 million

    Non current assets

    $139.22M
    CDNA annual long term assets is $139.22 million

    Current assets

    $351.83M
    CDNA annual total current assets is $351.83 million

    Cash and cash equivalents

    $114.69M
    CDNA annual cash & cash equivalents is $114.69 million

    Accounts receivable

    $64.61M
    CDNA annual accounts receivable is $64.61 million

    Inventory

    $19.50M
    CDNA annual inventory is $19.50 million

    Liabilities

    Total liabilities

    $112.62M
    CDNA annual total liabilities is $112.62 million

    Long term liabilities

    $23.25M
    CDNA annual total long term liabilities is $23.25 million

    Current liabilities

    $89.37M
    CDNA annual total current liabilities is $89.37 million

    Accounts payable

    $7.69M
    CDNA annual accounts payable is $7.69 million

    Debt

    Total debt

    $28.37M
    CDNA annual total debt is $28.37 million

    Total debt 1-year change

    -17.11%
    CDNA annual total debt is down -17.11% year-on-year

    Long term debt

    $22.26M
    CDNA annual long term debt is $22.26 million

    Short term debt

    $6.10M
    CDNA annual short term debt is $6.10 million

    Equity & Capital

    Shareholders equity

    $378.43M
    CDNA annual stockholders equity is $378.43 million

    Book value

    $378.43M
    CDNA annual book value is $378.43 million

    Retained earnings

    -$626.24M
    CDNA annual retained earnings is -$626.24 million

    Working capital

    $262.46M
    CDNA annual working capital is $262.46 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $38.05M
    CDNA annual cash flow from operations is $38.05 million

    Cash from operations 1-year change

    +306.92%
    CDNA annual cash flow from operations is up +306.92% year-on-year

    Cash from investing

    -$483.00K
    CDNA annual cash flow from investing activities is -$483.00 thousand

    Cash from investing 1-year change

    -101.19%
    CDNA annual cash flow from investing activities is down -101.19% year-on-year

    Cash from financing

    -$5.61M
    CDNA annual cash flow from financing activities is -$5.61 million

    Cash from financing 1-year change

    +81.06%
    CDNA annual cash flow from financing activities is up +81.06% year-on-year

    CAPEX

    CAPEX

    $6.48M
    CDNA annual capital expenditures is $6.48 million

    CAPEX 1-year change

    -29.83%
    CDNA annual capital expenditures is down -29.83% year-on-year

    Free Cash Flow

    Free cash flow

    $31.56M
    CDNA annual free cash flow is $31.56 million

    Free cash flow 1-year change

    +214.25%
    CDNA annual free cash flow is up +214.25% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    67.16%
    CDNA annual gross profit margin is 67.16%

    Operating margin

    -16.10%
    CDNA annual operating profit margin is -16.10%

    Net margin

    15.74%
    CDNA annual net profit margin is 15.74%

    ROA & ROE

    ROA

    10.97%
    CDNA annual return on assets is 10.97%

    ROE

    16.43%
    CDNA annual return on equity is 16.43%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    11.12
    CDNA price to earnings ratio is 11.12

    PE ratio Sector rank

    16.98%
    CDNA price to earnings ratio is higher than 16.98% of companies in Healthcare sector

    PB Ratio

    PB ratio

    1.88
    CDNA price to book ratio is 1.88

    PB ratio Sector rank

    52.61%
    CDNA price to book ratio is higher than 52.61% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.06
    CDNA price to sales ratio is 2.06

    PS ratio Sector rank

    38.4%
    CDNA price to sales ratio is higher than 38.4% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $653.69M
    CDNA enterprise value is $653.69 million

    Enterprise value Sector rank

    68.39%
    CDNA enterprise value is higher than 68.39% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -28.48
    CDNA EV/EBITDA is -28.48

    EV/EBITDA Sector rank

    6.34%
    CDNA EV/EBITDA is higher than 6.34% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.94
    CDNA annual current ratio is 3.94

    Quick ratio

    3.72
    CDNA annual quick ratio is 3.72

    Leverage

    Debt to equity

    0.00
    CDNA annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CDNA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    6
    CDNA piotroski f-score is 6

    Altman Z-Score

    2.97
    CDNA altman z-score is 2.97

    Analyst ratings

    Recent major analysts updates

    Jul 18, 25 Craig-Hallum
    Buy
    May 5, 25 Stephens & Co.
    Overweight
    May 5, 25 HC Wainwright & Co.
    Neutral
    Apr 17, 25 Goldman Sachs
    Buy
    Mar 3, 25 HC Wainwright & Co.
    Neutral
    Feb 27, 25 Stephens & Co.
    Overweight
    Jan 15, 25 Wells Fargo
    Equal-Weight
    Jan 14, 25 HC Wainwright & Co.
    Neutral
    Nov 5, 24 BTIG
    Buy
    Oct 22, 24 HC Wainwright & Co.
    Neutral

    Institutional Ownership

    Screeners with CDNA included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for CareDx, Inc?
    • Does CareDx, Inc pay dividends?
    • What sector is CareDx, Inc in?
    • What industry is CareDx, Inc in?
    • What country is CareDx, Inc based in?
    • When did CareDx, Inc go public?
    • Is CareDx, Inc in the S&P 500?
    • Is CareDx, Inc in the NASDAQ 100?
    • Is CareDx, Inc in the Dow Jones?
    • When was CareDx, Inc's last earnings report?
    • When does CareDx, Inc report earnings?

    What is the ticker symbol for CareDx, Inc?

    The ticker symbol for CareDx, Inc is NASDAQ:CDNA

    Does CareDx, Inc pay dividends?

    No, CareDx, Inc does not pay dividends

    What sector is CareDx, Inc in?

    CareDx, Inc is in the Healthcare sector

    What industry is CareDx, Inc in?

    CareDx, Inc is in the Diagnostics & Research industry

    What country is CareDx, Inc based in?

    CareDx, Inc is headquartered in United States

    When did CareDx, Inc go public?

    CareDx, Inc's initial public offering (IPO) was on July 17, 2014

    Is CareDx, Inc in the S&P 500?

    No, CareDx, Inc is not included in the S&P 500 index

    Is CareDx, Inc in the NASDAQ 100?

    No, CareDx, Inc is not included in the NASDAQ 100 index

    Is CareDx, Inc in the Dow Jones?

    No, CareDx, Inc is not included in the Dow Jones index

    When was CareDx, Inc's last earnings report?

    CareDx, Inc's most recent earnings report was on April 30, 2025

    When does CareDx, Inc report earnings?

    The next expected earnings date for CareDx, Inc is August 6, 2025
    On this page